ACTUALIDAD NEUROFIX
Neurofix Pharma presenta los exitosos resultados de la fase IIA de su ensayo clínico ante instituciones y empresarios en Salamanca28 de November de 2022 - 08:46
Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial11 de November de 2022 - 15:42
Neurofix Pharma enters the ‘club of the chosen ones’ by reaching the last phase of one of the most competitive EU calls.10 de November de 2022 - 09:03
Neurofix Pharma presenta los exitosos resultados de la fase IIA de su ensayo clínico ante instituciones y empresarios en Salamanca
Mañueco visits the offices of Neurofix Pharma, the first biotech company in Castilla y León to successfully complete phase IIA of a clinical trial
Neurofix Pharma enters the ‘club of the chosen ones’ by reaching the last phase of one of the most competitive EU calls.